Alzheimer's pathology: should peripheral monocytes and CCR2 take center stage?

Author： Harries Lorna W   Pilling Luke C   Lampron Antoine   Rivest Serge   Melzer David  

Publisher： Future Medicine

ISSN： 1758-2024

Source： Neurodegenerative Disease Management, Vol.3, Iss.1, 2013-02, pp. : 9-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alzheimer's disease: is the clue in the eyes?

By Crawford Trevor J  

Neurodegenerative Disease Management, Vol. 3, Iss. 1, 2013-02 ,pp. : 5-7

Future Medicine

Access to resources Recommend Favorite

Alzheimer's disease and type 2 diabetes: Two diseases, one common link?

By Bartl Jasmin  

World Journal of Biological Psychiatry, Vol. 14, Iss. 3, 2013-04 ,pp. : 233-240

Informa Healthcare

Access to resources Recommend Favorite

Should the Retention trial of the Test of Memory Malingering be optional?

By Greve Kevin W.   Bianchini Kevin J.  

Archives of Clinical Neuropsychology, Vol. 21, Iss. 1, 2006-01 ,pp. : 117-119

Oxford University Press

Access to resources Recommend Favorite

IV. How should the outcome of the conference be implemented?

By  

Archives of Clinical Neuropsychology, Vol. 13, Iss. 2, 1998-03 ,pp. : 237-249

Oxford University Press

Access to resources Recommend Favorite

Ask the Expert: How should vascular dementia be managed?

By Jellinger Kurt A  

Neurodegenerative Disease Management, Vol. 3, Iss. 2, 2013-04 ,pp. : 109-113

Future Medicine

Access to resources Recommend Favorite